Physiological role of somatostatin-mediated autofeedback regulation for growth hormone: importance of growth hormone in triggering somatostatin release during a trough period of pulsatile growth hormone release in conscious male rats.
In mammals including human, it is generally accepted that growth hormone (GH) can regulate its own secretion through an autofeedback mechanism in which somatostatin (SRIF) may be involved. To explore a physiological role of SRIF-mediated GH autoregulation, the effect of exogenous human GH administration on plasma rat GH response to [D-Ala2, Nle27]-human GH-releasing hormone-(1-28)-agmatine (hGHRH-analog), which does not crossreact with anti-rat GH-releasing hormone gamma-globulin (GHRH-Ab), was examined in conscious male rats treated with GHRH-Ab in the absence and presence of anti-SRIF gamma-globulin (SRIF-Ab). Enhanced SRIF release during a trough period of natural pulsatile GH secretion, suggested by the blunted GH response to exogenous hGHRH-analog, no longer occurred when major GH secretory bursts were abolished by GHRH-Ab treatment. On the other hand, when hGH was administered in GHRH-Ab-treated rats so as to simulate the quantity and dynamic change of GH in hypophysial portal circulation in rats exhibiting pulsatile GH secretion, hGHRH-analog-induced GH rises were significantly suppressed during the period corresponding to a GH trough. This suppression was completely prevented by simultaneous treatment with SRIF-Ab. Furthermore, administration of bovine GH, but not ovine prolactin, resulted in significant suppression of hGHRH-analog-provoked GH rises. These findings suggest that enhanced SRIF release during a trough period of spontaneous GH secretory rhythm is induced by the preceding GH secretory burst, and also suggest a possible role for SRIF-mediated GH autoregulation in a physiological state.
Sato
M
M
Department of Medicine, Kobe University School of Medicine, Japan.
Chihara
K
K
Kita
T
T
Kashio
Y
Y
Okimura
Y
Y
Kitajima
N
N
Fujita
T
T
D000376:Agmatine / Q000494:pharmacology*; D000818:Animals; D003429:Cross Reactions; D004305:Dose-Response Relationship, Drug; D005246:Feedback; D013006:Growth Hormone / Q000031:analogs & derivatives / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology; D013007:Growth Hormone-Releasing Hormone / Q000031:analogs & derivatives* / Q000276:immunology / Q000494:pharmacology; D006146:Guanidines / Q000494:pharmacology*; D006706:Homeostasis; D019382:Human Growth Hormone; D007106:Immune Sera / Q000008:administration & dosage / Q000276:immunology; D008297:Male; D010507:Periodicity; D051381:Rats; D011919:Rats, Inbred Strains; D017337:Sermorelin / Q000031:analogs & derivatives*; D013004:Somatostatin / Q000276:immunology / Q000378:metabolism / Q000502:physiology*
D006146:Guanidines; D007106:Immune Sera; C052685:DBO 29; D019382:Human Growth Hormone; D013004:Somatostatin; D000376:Agmatine; D017337:Sermorelin; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone